Lista de obras -

150. Relative Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults—United States, 2015–2017

scholarly article by Joshua Doyle et al published November 2018 in Open Forum Infectious Diseases

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type

artículo científico

2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States

artículo científico publicado en 2018

2062. Improving Antibiotic Prescribing in the Ambulatory Care Setting—Stewardship through Influenza Vaccination, US Flu VE Network 2013–2014 Through 2017–2018

2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018

2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-associated Hospitalizations Among Immunocompromised Adults—2017–2018

2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018

535Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network.

artículo científico publicado en 2014

650Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network.

artículo científico publicado en 2014

900. Effect of Influenza Vaccine Priming on Current Season Vaccine Effectiveness among Children and Adolescents, US Flu VE Network 2014–2015 Through 2017–2018

988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018

995. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among High-Risk Adults in the United States, 2015–2016

Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine.

artículo científico publicado en 2013

Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine

scientific article published on 05 October 2018

Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons

artículo científico publicado en 2017

COVID-19 Vaccination Perspectives and Illnesses Among Law Enforcement Officers, Firefighters, and Other First Responders in the US, January to September 2021

artículo científico publicado en 2022

Classification and Regression Tree (CART) analysis to predict influenza in primary care patients

artículo científico publicado en 2016

Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel

artículo científico publicado en 2015

Consistency of influenza A virus detection test results across respiratory specimen collection methods using real-time reverse transcription-PCR.

artículo científico publicado en 2013

Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.

artículo científico publicado en 2015

Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial

artículo científico publicado en 2022

Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020

scientific article published on 25 December 2020

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

artículo científico publicado en 2022

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION N

artículo científico

Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults

artículo científico publicado en 2021

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017

scientific article published on 01 February 2020

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States

artículo científico publicado en 2015

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season

artículo científico

Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—Nine States, January–September 2021

artículo científico publicado en 2022

Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season

artículo científico publicado en 2019

Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.

artículo científico publicado en 2016

Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18

scientific article published on 07 June 2020

Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

artículo científico publicado en 2016

Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes

artículo científico publicado en 2015

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease

artículo científico publicado en 2015

Hospitalization following Outpatient Medical Care for Influenza: US Influenza Vaccine Effectiveness Network, 2011-12-2015-16

artículo científico publicado en 2018

Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013

artículo científico publicado en 2015

Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with measles-mumps-rubella and varicella vaccines in children less than 2 years of age

artículo científico publicado en 2011

Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons

artículo científico publicado en 2015

Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States

artículo científico publicado en 2018

Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016.

artículo científico publicado en 2018

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

artículo científico publicado en 2016

Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016.

artículo científico publicado en 2017

Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017

scientific article published on 01 May 2019

Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses

artículo científico publicado en 2015

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season.

artículo científico publicado en 2017

Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season

artículo científico publicado en 2017

Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season

artículo científico publicado en 2019

Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020

artículo científico publicado en 2020

Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016

artículo científico publicado en 2018

Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018

scientific article published on 09 April 2020

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.

artículo científico publicado en 2018

Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates

artículo científico publicado en 2013

Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type

artículo científico publicado en 2014

Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017.

artículo científico publicado en 2017

Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

artículo científico publicado en 2018

Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019

article

Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020

artículo científico publicado en 2020

Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022

artículo científico

Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014.

artículo científico publicado en 2014

Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018

article

Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

artículo científico publicado en 2020

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons

PS3-51: Variation in the Self-Care Behaviors of Healthcare Personnel: Physicians, Nurses, and Others

Paid Leave and Access to Telework as Work Attendance Determinants during Acute Respiratory Illness, United States, 2017-2018

scientific article published on 01 January 2020

Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness

scientific article published on 04 May 2020

Potential influence of seasonal influenza vaccination requirement versus traditional vaccine promotion strategies on unvaccinated healthcare personnel.

artículo científico publicado en 2013

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

scholarly article by Mark G Thompson published in 2021

Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

artículo científico publicado en 2018

Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States

artículo científico publicado en 2017

Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination

scientific article published on 23 April 2020

Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults - United States, 2015-2017

artículo científico publicado en 2020

Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19

scientific article published on 12 August 2020

Reply to Yager and Doll

artículo científico publicado en 2020

Role of Age in Spread of Influenza, 2011-2019, U.S. Influenza Vaccine Effectiveness Network

artículo científico publicado en 2021

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine

artículo científico publicado en 2016

Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season

artículo científico publicado en 2020

Systematic testing for influenza and COVID-19 among patients with respiratory illness

artículo científico publicado en 2020

The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel

artículo científico publicado en 2012

Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season

artículo científico publicado en 2014

Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season

artículo científico publicado en 2015

Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network

artículo científico publicado en 2020

mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged ≥16 Years in the United States, February – May 2021

artículo científico publicado en 2021

Lista de obras de

150. Relative Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults—United States, 2015–2017

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type

2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States

2062. Improving Antibiotic Prescribing in the Ambulatory Care Setting—Stewardship through Influenza Vaccination, US Flu VE Network 2013–2014 Through 2017–2018

2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018

2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-associated Hospitalizations Among Immunocompromised Adults—2017–2018

2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018

535Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network.

650Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network.

900. Effect of Influenza Vaccine Priming on Current Season Vaccine Effectiveness among Children and Adolescents, US Flu VE Network 2014–2015 Through 2017–2018

988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018

995. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among High-Risk Adults in the United States, 2015–2016

Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine.

Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine

Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons

COVID-19 Vaccination Perspectives and Illnesses Among Law Enforcement Officers, Firefighters, and Other First Responders in the US, January to September 2021

Classification and Regression Tree (CART) analysis to predict influenza in primary care patients

Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel

Consistency of influenza A virus detection test results across respiratory specimen collection methods using real-time reverse transcription-PCR.

Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.

Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial

Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION N

Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season

Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—Nine States, January–September 2021

Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season

Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.

Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18

Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease

Hospitalization following Outpatient Medical Care for Influenza: US Influenza Vaccine Effectiveness Network, 2011-12-2015-16

Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013

Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with measles-mumps-rubella and varicella vaccines in children less than 2 years of age

Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons

Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States

Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016.

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016.

Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017

Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season.

Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season

Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season

Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020

Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016

Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.

Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates

Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type

Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017.

Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019

Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020

Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022

Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014.

Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018

Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons

PS3-51: Variation in the Self-Care Behaviors of Healthcare Personnel: Physicians, Nurses, and Others

Paid Leave and Access to Telework as Work Attendance Determinants during Acute Respiratory Illness, United States, 2017-2018

Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness

Potential influence of seasonal influenza vaccination requirement versus traditional vaccine promotion strategies on unvaccinated healthcare personnel.

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)

Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States

Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination

Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults - United States, 2015-2017

Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19

Reply to Yager and Doll

Role of Age in Spread of Influenza, 2011-2019, U.S. Influenza Vaccine Effectiveness Network

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine

Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season

Systematic testing for influenza and COVID-19 among patients with respiratory illness

The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel